주식/증권 📉 부정적

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

Yahoo Finance 07/09/2026 05:34:00 PM 8회

요약

bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and regulatory risks keep pressure on the stock.

원문 기사 보기

관련 뉴스

WisdomTree outlines ~15 ETF launches over next 18 months as it guides 152M-155M diluted shares for H2

Warner Bros. gains on report Newsom concerned about AG suit over Paramount deal

Sony's Spider-Man: Brand New Day tracks toward a huge box office weekend

Moog signals FY 2026 adjusted EPS of $11.65±$0.10 as tariff refund adds $0.70 per share

뉴스 목록으로